Fig. 3
2D and 3D illustrations of the expected binding modes for (a) co-crystal ligand (Y21), (b): compound 1, (c): compound 2 with Topoisomerase IV active site.
Fig. 3 | Scientific Reports
2D and 3D illustrations of the expected binding modes for (a) co-crystal ligand (Y21), (b): compound 1, (c): compound 2 with Topoisomerase IV active site.
